Summary
The different members of the endothelin peptide family exhibit potent, long-lasting
vasoconstrictive effects and thus play a central role in blood pressure regulation.
However, endothelins have also been shown to modulate renal, cardiac and immune functions
under physiological and pathophysiological conditions. In addition, endothelins are
thought to be involved in the progression of some types of tumours. Soon after their
discovery in 1988, it was shown that endothelins affect hormone release in the pituitary.
Moreover, the intrapituitary production and expression of both endothelins and endothelin
receptors have been described. This review summarises the present day knowledge concerning
the expression and regulation of intrapituitary endothelins and their receptors. In
addition, the effects of endothelins on hormone production by anterior, intermediate
and posterior pituitary cell types are reviewed and their importance for pituitary
physiology and pathophysiology is discussed.
Key words:
Endothelins - Endothelin receptors - Anterior pituitary - Posterior pituitary - Pituitary
hormones
References
- 1
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S.
Cloning and expression of a cDNA encoding an endothelin receptor.
Nature.
1990;
348
730-732
- 2
Arzt E, Stelzer G, Renner U, Lange M, Mueller O A, Stalla G K.
Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma
and murine pituitary cell cultures.
J Clin Invest.
1992;
90
1944-1951
- 3
Arzt E, Paez Pereda M, Perez Castro C, Pagotto U, Renner R, Stalla G K.
Pathophysiological role of the cytokine network in the anterior pituitary gland.
Front Neuroendocrinol.
1999;
20
71-95
- 4
Battistini B, Chailler P, D'Orléans-Juste P, Brière N, Sirois P.
Growth regulatory properties of endothelins.
Peptides.
1993;
14
385-399
- 5
Ben-Baruch G, Schiff E, Galron R, Menczer J, Sokolovsky M.
Impaired binding properties of endothelin-1 receptors in human endometrial carcinoma
tissue.
Cancer.
1993;
72
1955-1958
- 6
Berthiaume N, Yanagisawa M, Labonte J, D'Orléans-Juste P.
Heterozygous knock-out of ET(B) receptors induces BQ-123-sensitive hypertension in
the mouse.
Hypertension.
2000;
36
002-1007
- 7
Billiard J.
Functional heterogeneity of pituitary gonadotropes in response to a variety of neuromodulators.
Mol Cell Endocrinol.
1996;
123
163-170
- 8
Burris T P, Kanyicska B, Freeman M E.
Inhibition of prolactin secretion by endothelin-3 is pertussis toxin-sensitive.
Eur J Pharmacol.
1991;
198
223-225
- 9
Calogero A E, Raiti F, Nicolosi G, Burrello G, D'Agata R, Mantero F.
Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing
hormone and pituitary ACTH release in vitro.
J Endocrinol.
1994;
140
419-424
- 10
Calvo J J, Gonzalez R, de Carvalho L F, Takahashi K, Kanse S M, Hart G R, Ghatei M A,
Bloom S R.
Release of substance P from rat hypothalamus and pituitary by endothelin.
Endocrinology.
1990;
126
2288-2295
- 11
Cesnjaj M, Zheng L, Catt K J, Stojilkovic S S.
Dependence of stimulus-transcription coupling on phospholipase D in agonist-stimulated
pituitary cells.
Mol Biol Cell.
1995;
6
1037-1047
- 12
Domae M, Yamada K, Hanabusa Y, Furukawa T.
Inhibitory effects of endothelin-1 and endothelin-3 on prolactin release: possible
involvement of endogenous endothelin isopeptides in the rat anterior pituitary.
Life Sci.
1992;
50
715-722
- 13
Domae M, Yamada K, Inoue T, Satoh M, Furukawa T.
Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary
gland: possible involvement of ETA Receptor activation and Prostaglandin E2 production.
J Pharmacol Exp Ther.
1994;
270
55-69
- 14
Dymshitz J, Laudon M, Ben-Jonathan N.
Endothelin-induced response of lactotrophs cultured under different conditions.
Neuroendocrinology.
1992;
55
724-729
- 15
Elshourbagy N A, Adamou J E, Gagnon A W, Wu H L, Pullen M, Nambi P.
Molecular characterization of a novel human endothelin receptor splice variant.
J Biol Chem.
1996;
271
25300-25307
- 16
Furudate S, Masaki Y, Muto T.
Induction of ovulation by endothelin-3 in rats.
J Endocrinol.
1994;
141
109-112
- 17
Furuya S, Hiroe T, Ozaki T, Takimoto M, Hori S.
Lokalization of endothelin A receptors in rat pituitary TSH cells: light- and electron-microscopic
immunohistochemical studies.
Cell Tissue Res.
2000;
302
85-94
- 18
Gajkowska B, Viron A.
Localization of endothelin-like immunoreactivity in the hypothalamo-neurohypophysial
system of the rat after ischemia.
Folia Neuropathol.
1996;
34
173-177
- 19
Gajkowska B, Viron A.
Protracted elevation of endothelin immunoreactivity in hypothalamo-neurohypophysial
system after ischemia.
Folia Neuropathol.
1997;
35
107-114
- 20
Greer I A, Thomas G B, Brooks A N.
Endothelin stimulates ACTH secretion in the ovine fetus.
Reprod Fertil Dev.
1995;
7
1231-1236
- 21
Gulati A, Srimal R C.
Endothelin Mechanisms in the central nervous system: a target for drug development.
Drug Development Res.
1992;
26
361-387
- 22
Haak T, Jungmann E, Raab C, Usadel K H.
Elevated endothelin-1 levels after cigarette smoking.
Metabolism.
1994;
43
267-269
- 23
Haak T, Jungmann E, Haak E, Ehrlich S, Usadel K H.
Clinical evidence for a neuromodulator action of endothelin in the hypothalamic-pituitary-adrenal
axis in man.
Exp Clin Endocrinol Diabetes.
1997;
105
46-52
- 24
Hagiwara H, Nagasawa T, Yamamoto T, Lodhi K M, Ito T, Takemura N, Hirose S.
Immunochemical characterization and localization of endothelin ETB receptor.
Am J Physiol.
1993;
264
R777-R783
- 25
Harland S P, Kuc R E, Pickard J D, Chir M, Davenport A P.
Expression of endothelin-A receptors in human gliomas and meningiomas, with high affinity
for the selective antagonist PD 156707.
Neurosurgery.
1998;
43
890-899
- 26
Himeno A, Shigematsu K, Taguchi T, Niwa M.
Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland:
Interaction in the recognition of endothelin-1 between ETA and ETB receptor.
Cell Mol Neurobiol.
1998;
18
447-452
- 27
Hirai M, Miyabo S, Ooya E, Miyanaga K, Aoyagi N, Kimura K, Kishida S, Nakai T.
Endothelin-3 stimulates the hypothalamic-pituitary-adrenal-axis.
Life Sci.
1991;
48
2359-2363
- 28
Hori S, Komatsu Y, Shigemoto R, Mizuno N, Naganishi S.
Distinct tissue distribution and cellular localization of two messenger ribonucleic
acids encoding different subtypes of rat endothelin receptors.
Endocrinology.
1992;
130
1885-1895
- 29
Hosoda K, Nakao K, Arai H, Suga S, Ogawa Y, Mukoyama M, Shirakami G, Saito Y, Nakanishi S,
Imura H.
Cloning and expression of human endothelin-1 receptor cDNA.
FEBS Lett.
1991;
287
23-26
- 30
Hosoda K, Nakao K, Tamura N, Arai H, Ogawa Y, Suga S, Nakanishi S, Imura H.
Organization, structure, chromosomal assignment, and expression of the gene encoding
the human endothelin-A receptor.
J Biol Chem.
1992;
267
18797-18804
- 31
Huggins J P, Pelton J T, Miller R C.
The structure and specifity of endothelin receptors: their importance in physiology
and medicine.
Pharmacol Therapeut.
1993;
59
55-123
- 32
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T.
The human endothelin family: three structurally and pharmacologically distinct isopeptides
predicted by three separate genes.
Proc Natl Acad Sci USA.
1989;
86
2863-2867
- 33
Ishibashi M, Fujita M, Nagai K, Kako M, Furue H, Haku E, Osamura Y, Yamaji T.
Production and secretion of endothelin by hepatocellular carcinoma.
J Clin Endocrinol Metab.
1993;
76
378-383
- 34
Jessop D S.
Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal
axis.
J Endocrinol.
1999;
160
169-180
- 35
Jones C R, Hiley C R, Pelton J T, Mohr M.
Audioradiographic visualization of the binding sites for [125I]endothelin in rat and human brain.
Neurosci Lett.
1989;
97
276-279
- 36
Kacsóh B, Tóth B E, Avery L M, Grosvenor C E.
In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary
glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine
and somatostatin.
Life Sci.
1993;
52
259-269
- 37
Kanyicska B, Burris T B, Freeman M E.
Endothelin-3 inhibits prolactin and stimulates LH, FSH, and TSH secretion from pituitary
cell culture.
Biochem Biophys Res Commun.
174
1991a;
338-343
- 38
Kanyicska B, Burris T B, Freeman M E.
The effects of endothelins on the secretion of prolactin, luteinizing hormone, and
follicle-stimulating hormone are mediated by different guanine nucleotide-binding
proteins.
Endocrinology.
129
1991b;
2607-2613
- 39
Kanyicska B, Freeman M E.
Characterization of endothelin receptors in the anterior pituitary gland.
Am J Physiol.
1993;
265
E601-E608
- 40
Kanyicska B, Livingstone J D, Freeman M E.
Long term exposure to dopamine reverses the inhibitory effect of endothelin-1 on prolactin
secretion.
Endocrinology.
1995;
136
990-994
- 41
Kanyicska B, Freeman M E, Dryer S E.
Endothelin activates large-conductance K+ channels in rat lactotrophs: reversal by long-term exposure to dopamine agonist.
Endocrinology.
1997;
138
3141-3153
- 42
Kanyicska B, Lerant A, Freeman M E.
Endothelin is an autocrine regulator of prolactin secretion.
Endocrinology.
1998;
139
5164-5173
- 43
Kanyicska B, Lerant A, Freeman M E.
Endothelin-like immunoreactivity in lactotrophs, gonadotrophs, and somatotrophs of
rat anterior pituitary gland are affected differentially by ovarian steroid hormones.
Endocrine.
2001;
14
263-268
- 44
Karne S, Jayawickreme C K, Lerner M R.
Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores.
J Biol Chem.
1993;
268
19126-19133
- 45
Kennedy R L, Haynes W G, Webb D J.
Endothelins as regulators of growth and function in endocrine tissues.
Clin Endocrinol.
1993;
39
259-265
- 46
Kiefer F, Kellner M, Jahn H, Wiedemann K.
Comparison of the effects of endothelin-1 and -3 on secretion of pituitary hormons
in healthy volunteers.
Exp Clin Endocrinol Diabetes.
1999;
108
378-381
- 47
Kloog Y, Sokolovsky M.
Similarities in mode and site of action of sarafotoxins and endothelins.
Trends Pharmac Sci.
1989;
10
212-215
- 48
Kohzuki M, Chai S Y, Paxinos G, Karavas A, Casley D J, Johnston C I, Mendelsohn F AO.
Localization and characterization of endothelin receptor binding sites in the rat
brain visualized by in vitro autoradiography.
Neuroscience.
1991;
42
245-260
- 49
Kumar C S, Mwangi V, Nuthulanganti P, Wu H-L, Pullen M, Brun K, Aiyar H, Morris R E,
Naughton R, Nambi P.
Cloning and characterization of a novel endothelin receptor from Xenopus heart.
J Biol Chem.
1994;
269
13414-13420
- 50
Kurihara M, Ochi A, Kawaguchi T, Niwa M, Kataoka Y, Mori K.
Localization and characterization of endothelin receptors in human gliomas: a growth
factor?.
Neurosurgery.
1990;
27
275-281
- 51
Kurokawa K, Yamada H, Liu Y, Kudo M.
Immunohistochemical distribution of the endothelin-converting enzyme-1 in rat hypothalamo-pituitary
axis.
Neurosci Lett.
2000;
284
81-84
- 52
Lachowicz A, Van Goor F, Katzur A C, Bonhomme G, Stojilkovic S S.
Uncoupling of calcium mobilization and entry pathways in endothelin-stimulated pituitary
lactotrophs.
J Biol Chem.
1997;
272
28308-28314
- 53
Ladenheim R G, Lacroix I, Foignant-Chaverot N, Strosberg A D, Couraud P O.
Endothelins stimulate c-fos and nerve growth factor expression in astrocytes and astrocytoma.
J Neurochem.
1993;
60
260-266
- 54
Lange M, Pagotto U, Hopfner U, Ehrenreich H, Oeckler R, Sinowatz F, Stalla G K.
Endothelin expression in normal human anterior pituitaries and pituitary adenomas.
J Clin Endocrinol Metab.
1994;
79
1864-1870
- 55
Lewy H, Galron R, Bdolah A, Sokolovsky M, Naor Z.
Paradoxical signal transduction mechanism of endothelins and safarotoxins in cultured
pituitary cells: stimulation of phosphoinositide turnover and inhibition of prolactine
release.
Mol Cell Endocrinol.
1992;
89
1-9
- 56
McMillen M A, Sumpio B E.
Endothelins: polyfuntional cytokines.
J Am Coll Surg.
1995;
180
1037-1047
- 57
Makino S, Hashimoto K, Hirasawa R, Hattori T, Kageyama J, Ota Z.
Central interaction between endothelin and brain natriuretic peptide on pressure and
hormonal responses.
Brain Res.
1990;
534
117-121
- 58
Malendowicz L K, Nussdorfer G G, Meneghelli V, Nowak M, Markowska A, Majchrzak M.
Effects of endothelin-1 on the rat pituitary-adrenocortical axis under basal and stressful
conditions.
Endocr Res.
1997;
23
349-364
- 59
Malendowicz L K, Belloni A S, Nussdorfer G G, Hochol A, Nowak M.
Arginine-vasopressin and corticotropin-releasing hormone are sequentially involved
in the endothelin-1-induced acute stimulation of rat pituitary-adrenocortical axis.
J Steroid Biochem Molec Biol.
1998;
66
45-49
- 60
Mansour V M, Clarke I J, Smith A I.
The characterization, localization and regulation of endothelin in ovine pars intermedia.
Regul Pept.
1997;
70
55-65
- 61
Masaki T.
Endothelins: homeostatic and compensatory actions in the circulatory and endocrine
systems.
Endocr Rev.
1993;
14
256-268
- 62
Matsumoto H, Suzuki N, Onda H, Fujino M.
Abundance of endothelins-3 in rat intestine, pituitary gland and brain.
Biochem Biophys Res Commun.
1989;
164
74-80
- 63
Matsumoto H, Suzuki N, Shiota K, Inoue K, Tsuda M, Fujino M.
Insulin-like growth factor-1 stimulates endothelin-3 secretion from rat anterior pituitary
cells in primary culture.
Biochem Biophys Res Commun.
1990;
172
661-668
- 64
Miyata S, Furuya K, Nakai S, Bun H, Kiyohara T.
Morphological plasticity and rearrangement of cytoskeletons in pituicytes from adult
rat neurohypophysis.
Neurosci Res.
1999;
33
299-306
- 65
Nakai S, Furuya K, Miyata S, Kiyohara T.
Intracellular Ca2+ responses to nucleotides, peptides, amines, amino acids and prostaglandins in cultured
pituicytes from adult rat neurohypophysis.
Neurosci Lett.
1999;
266
185-188
- 66
Nakamoto H, Suzuki H, Murakami M, Kageyama Y, Ohishi A, Fukuda K, Hori S, Saruta T.
Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones
in conscious dogs.
Clin Sci.
1989;
77
567-572
- 67
Nakamura S, Naruse M, Naruse K, Shioda S, Nakai Y, Uemura H.
Colocalization of Immunoreactive Endothelin-1 and neurohypophysial hormones in the
axons of the neural lobe of the rat pituitary.
Endocrinology.
1993;
132
530-533
- 68
Naruse M, Naruse K, Nishikawa T, Yoshihara I, Ohsumi K, Suzuki N, Demura R, Demura H.
Endothelin-3 immunoreactivity in gonadotrophs of the human anterior pituitary.
J Clin Endocrinol Metab.
1992;
74
968-972
- 69
Naruse M, Naruse K, Demura H.
Recent advances in endothelin research on cardiovascular and endocrine system.
Endocr J.
1994;
41
491-507
- 70
Ogawa Y, Nakao K, Arai H, Nakagawa O, Hosoda K, Suga S, Nakanishi S, Imura H.
Molecular cloning of a non-isopeptide-selective human endothelin receptor.
Biochem Biophys Res Commun.
1991;
178
248-255
- 71
Ortmann O, Wassmann D, Stojilkovic S S, Catt K J, Schulz K-D, Emons G.
Ovarian steroids modulate endothelin-induced luteinizing hormone secretion from cultured
rat pituitary cells.
Endocrinology.
1993;
133
2632-2638
- 72
Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton C J, Lange M, Uhl E,
Weindl A, Stalla G K.
Expression and localization of endothelin-1 and endothelin-receptors in human meningiomas:
evidence for a role in tumoral growth.
J Clin Invest.
1995a;
96
2017-2025
- 73
Pagotto U, Arzberger T, Hopfner U, Renner U, Boscaro M, Stalla G K.
Endothelin-A receptor mRNA expression in human pituitary adenomas and meningeomas.
J Endocrinol Invest.
1995b;
18
((Suppl to no. 5))
95
- 74
Pagotto U, Arzberger T, Pistorello M, Renner U, Lange M, Uhl E, Strasburger C J, Stalla G K.
Endothelin receptors in human normal pituitary and pituitary adenomas.
J Endocrinol Invest.
19
((Suppl to no 5))
1996;
32
- 75
Plonowski A, Szymanska-Dcebinska T, Razikowska M, Baranowska B, Wozniewicz B.
Are m-opioid receptors involved in the control of endothelin-1 release from pituitary
gland in normal and dehydrated rats?.
Regul Pept.
1997;
69
89-94
- 76
Raab C, Weidmann E, Schmidt A, Bergmann L, Badenhoop K, Usadel K H, Haak T.
The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal
axis.
Clin Endocrinol.
1999;
50
37-44
- 77
Renner U, Pagotto U, Arzt E, Stalla G K.
Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic
substances in normal and tumorous pituitary function and growth: a review.
Eur J Endocrinol.
1996;
135
515-532
- 78
Ritz M-F, Stuenkel E L, Dayanithi G, Jones R, Nordmann J J.
Endothelin regulation of neuropeptide release from nerve endings of the posterior
pituitary.
Proc Natl Acad Sci USA.
1992;
89
8371-8375
- 79
Rossi N F.
Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo
in Long-Evans rats.
J Physiol.
1993;
461
501-511
- 80
Rossi N F.
Cation channel mechanisms in ET-3-induced vasopressin secretion by rat hypothalamo-neurohypophysial
explants.
Am J Physiol.
1995;
268
E467-E475
- 81
Rubanyi G M, Polokoff M A.
Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology.
Pharmacol Rev.
1994;
46
325-415
- 82
Saida K, Mitsui Y, Ishida N.
A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family.
J Biol Chem.
1989;
264
14613-14616
- 83
Saida K, Kometani N, Masuda H, Oka S, Uchide T.
Structure of mouse preproendothelin-3 and phylogenetic analysis of the endothelins.
J Cardiovasc Pharmacol.
36
((Suppl 1))
2000;
S1-S4
- 84
Sakamoto A, Yanagisawa M, Sakurai T, Takuwa Y, Yanagisawa M, Masaki T.
Cloning and functional expression of human cDNA for the ETB endothelin receptors.
Biochem Biophys Res Commun.
1991;
187
656-663
- 85
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T.
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.
Nature.
1990;
348
732-735
- 86
Samson W K, Skala K D, Alexander B D, Huang F-L S.
Pituitary site of action of endothelin: selective inhibition of prolactin release
in vitro.
Biochem Biophys Res Commun.
1990;
169
737-743
- 87
Samson W K, Skala K D, Alexander B D, Huang F-L S.
Possible neuroendocrine actions of endothelin-3.
Endocrinology.
1991a;
128
1465-1473
- 88
Samson W K, Skala K D, Alexander B D, Huang F-L S.
Hypothalamic endothelin: presence and effects related to fluid and electrolyte homeostasis.
J Cardiovasc Pharmacol.
1991b;
17
((Suppl 7))
S346-S349
- 89
Samson W K, Skala K D, Huang F-L S, Gluntz S, Alexander B D, Gomez-Sanchez C E.
Central nervous system action of endothelin-3 to inhibit water drinking in the rat.
Brain Res.
1991c;
593
347-351
- 90
Samson W K, Skala K D.
Comparison of the pituitary effects of the mammalian endothelins: vasoactive intestinal
contractor (endothelin-β, rat endothelin-2) is a potent inhibitor of prolactin secretion.
Endocrinology.
1992;
130
2964-2970
- 91
Samson W K, Skala K D, Alexander B D, Huang F-L S, Gomez-Sanchez C.
A prolactin release inhibiting activity isolated from neurointermediate lobe extracts
is an endothelin-like peptide.
Regul Pept.
1992;
39
103-112
- 92
Samson W K.
The endothelin-A receptor subtype transduces the effects of the endothelins in the
anterior pituitary gland.
Biochem Biophys Res Commun.
1992;
187
590-595
- 93
Shibata S, Himeno A, Shigematsu K, Tsusumi K, Sakurai-Yamashita Y, Yamashita K.
Endothelin receptors in pituitary gland.
Cell Mol Neurobiol.
1997;
17
89-100
- 94
Shymala V, Moulthrop T HM, Stratton-Thomas J, Tekamp-Olson P.
Two distinct human endothelin-B receptors generated by alternative splicing from a
single gene.
Cell Mol Biol Res.
1994;
40
285-296
- 95
Singh G, Thompson E B, Gulati A.
Altered endothelin-1 concentration in brain and peripheral regions during thyroid
dysfunction.
Pharmacology.
1994;
49
184-191
- 96
Sokolovsky M, Ambar I, Galron R.
A novel subtype of endothelin receptors.
J Biol Chem.
1992;
267
20551-20554
- 97
Sokolovsky M.
Endothelins and sarafotoxins: Physiological regulation, receptor subtypes and transmembrane
signaling.
Pharmac Ther.
1994a;
54
129-149
- 98
Sokolovsky M.
Endothelins and sarafotoxins: receptor heterogeneity.
Int J Biochem.
1994b;
26
335-340
- 99
Stiles J D, Ostrow P T, Balos L L, Greenberg S J, Plunkett R, Grand W, Heffner R R.
Correlation of endothelin-1 and transforming growth factor β1 with malignancy and
vascularity in human gliomas.
J Neuropathol Exp Neurol.
1997;
56
435-439
- 100
Stojilkovic S S, Merelli F, Iida T, Krsmanovic L Z, Catt K J.
Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior
pituitary cells.
Science.
1990;
248
1663-1666
- 101
Stojilkovic S S, Iida T, Merelli F, Catt K J.
Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary
cells.
Mol Pharmacol.
1991;
39
762-770
- 102
Stojilkovic S S, Balla T, Fukuda S, Cesnjaj M, Merelli F, Krsmanovic L Z, Catt K J.
Endothelin ET-A receptors mediate the signaling and secretory actions of endothelins
in pituitary gonadotrophs.
Endocrinology.
1992a;
130
465-474
- 103
Stojilkovic S S, Iida T, Cesnjaj M, Catt K J.
Differential actions of endothelin and gonadotropin-releasing hormone in pituitary
gonadotrophs.
Endocrinology.
1992b;
131
2821-2828
- 104
Stojilkovic S S, Catt K J.
Neuroendocrine actions of endothelins.
Trends Pharmacol Sci.
1992;
13
385-391
- 105
Stojilkovic S S, Tomic M, Kukuljan M, Catt K J.
Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmatic
oscillator.
Mol Pharmacol.
1994;
45
1013-1021
- 106
Stojilkovic S S, Catt K J.
Expression and signal transduction pathways of endothelin receptors in neuroendocrine
cells.
Front Neuroendocrin.
1996;
17
327-369
- 107
Takahashi K, Ghatei M A, Jones P M, Murphy J K, Lam H-C, O'Halloran J, Bloom S R.
Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin,
endothelin messenger ribonucleic acid and endothelin receptors.
J Clin Endocrin Metab.
1991;
72
693-699
- 108
Takahashi K, Satoh F, Murakami O, Totsune K, Sone M, Itoi K, Ohneda M, Mouri T.
Endothelin in ectopic ACTH-secreting bronchial carcinoid tumors.
J Cardiovasc Pharmacol.
22
((Suppl 8))
1993;
S288-S290
- 109
Takuwa Y.
Endothelin in vascular and endocrine systems: biological activities and its mechanisms
of action.
Endocr J.
1993;
40
489-506
- 110
Tomic M, Zivadinovic D, Van Goor F, Yuan D, Koshimizu T, Stojilkovic S S.
Expression of Ca2+-mobilizing endothelinA receptors and their role in the control of Ca2+ influx and growth hormone secretion in pituitary somatotrophs.
J Neurosci.
1999;
19
7721-7731
- 111
Uemura H, Naruse M, Nakamura S, Naruse K, Yamamoto T, Demura H, Hirohama T.
Immunoreactive endothelin-1 in the neural lobe of the rat pituitary following hemorrhage
and dehydration.
Endocr J.
1994;
41
685-691
- 112
Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C.
Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary
in a histiotypic cell aggregate culture system.
Neuroendocrinology.
1989;
49
102-106
- 113
Vermes I, Beishuizen A, Hampsink R M, Haanen C.
Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients:
possible role of endothelin and atrial natriuretic hormone.
J Clin Endocrinol Metab.
1995;
80
1238-1242
- 114
Vierhapper H, Hollenstein U, Roden M, Nowotny P.
Effect of endothelin-1 in man-impact on basal and stimulated concentrations of LH,
FSH, TSH, GH, ACTH and PRL.
Metabolism.
1993;
42
902-906
- 115
Vierhapper H.
Effect of endothelin-1 in man-impact on basal and stimulated concentration of luteinizing
hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin,
and prolactin with and without pretreatment with nifedipine.
Metabolism.
1996;
45
658-661
- 116
Wall K M, Ferguson A V.
Endothelin acts at the subfornical organ to influence the activity of putative vasopressin
and oxytocin-secreting neurons.
Brain Res.
1992a;
586
111-116
- 117
Wall K M, Nasr M, Ferguson A V.
Actions of endothelins at the subfornical organ.
Brain Res.
1992b;
570
180-187
- 118
Webber K M, Wallace C A, Smith A I, van den Buuse M.
Endothelin interactions with brain dopamine systems.
J Cardiovasc Pharmacol.
31
((Suppl 1)
1998;
S373-S375
- 119
Wu-Wong J R, Chiou W J, Magnuson S R, Witte D G, Lin C W.
Identification and characterization of type A endothelin receptors in MMQ cells.
Mol Pharmacol.
1993;
44
285-291
- 120
Wu-Wong J R, Chiou W J, Dixon D B, Opgenroth T J.
Dissociation characteristics of endothelin ETA receptor agonists and antagonists.
J Cardiovasc Pharmacol.
26
((Suppl 3)
1995;
S380-S384
- 121
Yahalom D, Rahimipour S, Koch Y, Ben-Aroya N, Fridkin M.
Structure-activity studies of reduced-size gonadotropin-releasing hormone agonists
derived from the sequence of an endothelin antagonist.
J Med Chem.
2000;
43
2824-2830
- 122
Yahalom D, Koch Y, Ben-Aroya N, Fridkin M.
Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary
gonadotropin-releasing hormone receptors.
Mol Pharmacol.
2000;
57
718-724
- 123
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K,
Masaki T.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature.
1988a;
332
411-415
- 124
Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe T X,
Sakakibara S, Goto K, Masaki T.
Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived
vasoconstrictor peptide.
Proc Natl Acad Sci USA.
1988b;
85
6964-6967
- 125
Yoshizawa T, Shinmi O, Giaid A, Yanagisawa M, Gibson S J, Uchiyama Y, Polak J M, Masaki T,
Kanazawa I.
Endothelin: a novel peptide in the posterior pituitary system.
Science.
1990;
247
462-464
- 126
Zheng L, Paik W Y, Cesnjaj M, Balla T, Tomic M, Catt K J, Stojilkovic S S.
Effects of the phospholipase-C inhibitor U73122, on signaling and secretion in pituitary
gonadotrophs.
Endocrinology.
1995;
136
1079-1088
Dr. Ulrich Renner
Max Planck Institute of Psychiatry
Department of Endocrinology
Kraepelinstr. 10
D-80804 Munich
Germany
Phone: +49-89-30622-349
Fax: +49-89-30622-605
Email: renner@mpipsykl.mpg.de